Lipid analogs for treating viral infections

Details Lipid analogs for treating viral infections Lipid analogs for treating viral infections

2006-11-14

2006-11-14

Coleman, Brenda (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Phosphorus esters

C558S169000, C558S170000, C558S172000, C558S174000, C514S077000

Reexamination Certificate

active

07135584

ABSTRACT:
A method of treating viral infections, and in particular HIV-1, hepatitis B virus, and herpes virus, is disclosed. The method comprises administering to a subject in need of such treatment an infection-controlling amount of a phospholipid or phospholipid derivative.

REFERENCES:
patent: 2086585 (1937-07-01), Taub et al.
patent: 2087132 (1937-07-01), Taub et al.
patent: 2108765 (1938-02-01), Domagk
patent: 2209383 (1940-07-01), Bock
patent: 2439969 (1948-04-01), Fourneau
patent: 2445393 (1948-07-01), Fourneau
patent: 2513747 (1950-07-01), Sallman et al.
patent: 2606909 (1952-08-01), Blicke
patent: 2689790 (1954-09-01), Mowry et al.
patent: 2950253 (1960-08-01), Kling et al.
patent: 3054678 (1962-09-01), Michener et al.
patent: 3694473 (1972-09-01), Eibl et al.
patent: 4093714 (1978-06-01), Tolman et al.
patent: 4096278 (1978-06-01), Queuille
patent: 4119714 (1978-10-01), Kny et al.
patent: 4159988 (1979-07-01), Eibl et al.
patent: 4221732 (1980-09-01), Oette et al.
patent: 4235877 (1980-11-01), Fullerton
patent: 4291024 (1981-09-01), Turcotte
patent: 4329302 (1982-05-01), Hanahan et al.
patent: 4426525 (1984-01-01), Hozumi et al.
patent: 4444766 (1984-04-01), Bosies et al.
patent: 4471113 (1984-09-01), MacCoss
patent: 4540521 (1985-09-01), Garst et al.
patent: 4559157 (1985-12-01), Smith et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4619917 (1986-10-01), Lee et al.
patent: 4622392 (1986-11-01), Hong et al.
patent: 4661509 (1987-04-01), Gordon et al.
patent: 4724232 (1988-02-01), Rideout et al.
patent: 4797479 (1989-01-01), Shuto et al.
patent: 4816450 (1989-03-01), Bell et al.
patent: 4820508 (1989-04-01), Wortzman
patent: 4826823 (1989-05-01), Cook et al.
patent: 4835263 (1989-05-01), Nguyen et al.
patent: 4837023 (1989-06-01), Eibl
patent: 4841039 (1989-06-01), Chu et al.
patent: 4880782 (1989-11-01), Eckstein et al.
patent: 4921951 (1990-05-01), Shuto et al.
patent: 4938949 (1990-07-01), Borch et al.
patent: 4992478 (1991-02-01), Geria
patent: 4997761 (1991-03-01), Jett-Tilton
patent: 5026687 (1991-06-01), Yarchoan et al.
patent: 5034394 (1991-07-01), Daluge
patent: 5138045 (1992-08-01), Cook et al.
patent: 5221696 (1993-06-01), Ke et al.
patent: 37 26 945 (1989-02-01), None
patent: 39 34 820 (1991-04-01), None
patent: 40 10 228 (1991-10-01), None
patent: 0 094 586 (1983-11-01), None
patent: 0 109 255 (1984-05-01), None
patent: 0 142 333 (1985-05-01), None
patent: 0 145 303 (1985-06-01), None
patent: 0 146 258 (1985-06-01), None
patent: 0 252 310 (1988-01-01), None
patent: 0 310 109 (1989-04-01), None
patent: 0 335 396 (1989-04-01), None
patent: 0 348 859 (1990-01-01), None
patent: 0 350 287 (1990-01-01), None
patent: 0 416 401 (1991-03-01), None
patent: 0 434 450 (1991-06-01), None
patent: 0 506 704 (1991-07-01), None
patent: 1561630 (1969-03-01), None
patent: 2 239 243 (1991-06-01), None
patent: 42-13841 (1967-08-01), None
patent: 49-100224 (1974-09-01), None
patent: 61-238793 (1986-10-01), None
patent: 10-293129 (1989-11-01), None
patent: 90/00555 (1990-01-01), None
patent: 90/05736 (1990-05-01), None
patent: 90/15601 (1990-12-01), None
patent: 91/05558 (1991-05-01), None
patent: 91/09602 (1991-07-01), None
patent: 91/18914 (1991-12-01), None
patent: 91/19726 (1991-12-01), None
patent: 92/03462 (1992-03-01), None
patent: 92/06192 (1992-04-01), None
patent: 93/00910 (1993-01-01), None
patent: 93/08807 (1993-05-01), None
patent: 93/16091 (1993-08-01), None
patent: 93/16092 (1993-08-01), None
patent: 93/17020 (1993-09-01), None
patent: 93/21191 (1993-10-01), None
Aggarwal, S. K. et al., “Synthesis and Biological Evaluation of Prodrugs of Zidovudine,”J. Med. Chem., 33, 1505-10, 1990.
Amari, J. V. et al., “Isolation of Experimental Anti-AIDS Glycerophospholipids by Micro-Preparative Reversed-Phase High-Performance Liquid Chromatography,”Journal of Chromatography, 590, 153-161, 1992.
Anderson, L. J. et al., “Antigenic Characterization of Respiratory Syncytial Virus Strains with Monoclonal Antibodies,”Journal of Infectious Diseases, 151:626-633, Apr. 1985.
Berdel, W. E. et al., “Cytotoxicity of Thioether-Lysophospholipids in Leukemias and Tumors of Human Origin,”Cancer Research, vol. 43, 5538-5543, 1983.
Boldanova, N. B. et al., “Protective Effect of Phosphatidylcholine-Containing Liposomes in Experimental Toxic Hepatitis,”Vopr. Med. Khim, 32, No. 3 (1986) Chemical Abstracts 105, p. 67, Abstract No. 35587k (1986).
Bosies, E. et al., “Preparation of Lecithin Analogs as Retrovirucides and Virucides,”Chemical Abstracts,115CA; 72142p, 1991.
Caliendo, A. M. et al., “Combination Therapy for Infection Due to Human Immunodeficiency Virus Type 1”,Clinical Infectious Diseases, vol. 18, pp. 516-524, 1994.
Chen, X. et al., “Design and Synthesis of Novel Nucleoside Analogs as Potential Antiviral Agents,” AbstractAmerican Assoc. of Pharmaceutical Scientists, vol. 9, No. 10, 1992.
Coe, D. M. et al., “Preparation of Nucleotide Mimics with Potent Inhibitory Activity Against HIV Reverse Transcriptase,”J. Chem. Soc. Perkin Trans 1, 3378-3379, 1991.
Crumpton, S. et al., “Novel Lipid Analogs with Cytostatic and Cytocidal Activity,”Anticancer Research, vol. 8, No. 6, pp. 1361-1366, Nov.-Dec. 1988.
Daniel, L. W. et al., “Alkyl-Linked Diglygerides Inhibit Protein Kinase C Activation by Diacylglycerols,”Biochemical&Biophysical Research Communications, 151, 291-97, Feb. 29, 1988.
Daniel, L. W. et al., “Characterization of Cells Sensitive and Resistant to ET-18-OCH3”Abstract 2447, Proceedings of the American Assoc. for Cancer Res., 31, 416, Mar. 1990.
Dietzfelbinger, “Cytotoxic and Purging Effects of ET-18-OCH3 in Human Malignant Lymphoid Cell Lines in Vitro,”Abstract 2472, Proceedings of the American Assoc. for Cancer Res., 31, 416, Mar. 1990.
Falsey A. R. et al., “Viral Respiratory Infections in the Institutionalized Elderly: Clinical and Epidemiologic Findings,”J Am Geriatric Soc., 40:115-119, 1992.
Fields, A. P. et al., “Human Immunodeficiency Virus Induces Phosphorylation of its Cell Surface Receptor,”Nature, 333, 278-80, May 19, 1988.
Fujiwara K., et al., “Comparison of Cell Kill Induced by Two Ether Lipids in Combination with Hyperthermia,”Proceedings of the American Association for Cancer Research; Preclinical Pharmacology Experimental Therapeutics, vol. 31, pp. 416, Abstract 2467, Mar. 1990.
Gill, P. S. et al., “Azidothymidine Associated with Bone Marrow Failure in the Acquired Immunodeficiency Syndrome (AIDS)”,Annals of Internal Medicine107: 502-505, 1987.
Glezen, W. P. et al., “Risk of Primary Infection and Reinfection with Respiratory Syncytial Virus,”Am J Dis Child, 140:543-546, 1986.
Gordeev, K. et al., “Synthesis of Thio Analogs of Platlet Activating Factor (PAF),”Bioorg. Khim., vol. 12, No. 7, pp. 951-955, 1986.
Graham, F. L. et al., “A New Technique for The Assay of Infectivity of Human Adenovirus 5-DNA,”Virology, vol. 52, pp. 456-467, 1973.
Hall, C. B. et al., “Infectivity of Respiratory Syncytial Virus by Various Routes of Inoculation,”Infect Immun., 33:779-783, 1981.
Hall, C. B. et al., “Nosocomial Respiratory Syncytial Virus Infections,”N Engl J Med., 293:1343-1346, 1975.
Hall, C. B. et al., “Respiratory Syncytial Virus Infections Within Families,”N Engl J Med, 294:414-419, 1976.
Hancock, J. et al., “Analogs of Natural Lipids. VII. Synthesis of Cyclopentanoid Analogs of Phosphatidylcholine,”Journal of Lipid Research, vol. 23, 183-189, 1982.
Harada, S. et al., “Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay,”Science, 229, 563-566, Aug. 9, 1985.
Hayashi, M et al., “Antitumor Activity of a Novel Nucleotide Derivative, 5′-(1,2 Dipalmitoyl-sn-glycero-3-phospho)-5-fluorouridine (TJ14026) on Murine Tumors,”Biol. Pharm. Bull., 16(8), 778-81, 1993.
Henderson,

Affiliated with

Also associated with

Rating

Lipid analogs for treating viral infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipid analogs for treating viral infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipid analogs for treating viral infections will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3678618